Skip to main content

Table 1 Measurement schedule for the participants of the ENVIS-ion trial.

From: Aspirin for the prevention of cognitive decline in the elderly: rationale and design of a neuro-vascular imaging study (ENVIS-ion)

  Recruitment, Screening & Baseline Annualreview (1 yr) Annualreview (3 yr) Annualreview (5 yr)
ENVIS-ion study     
Brain MRI & RVI X   X  
Additional cognitive function testsa X   X  
ASPREE parent study     
Inclusion/exclusion criteria; informed consent X    
Cognitive function testsb X X X X
Demographics & physical measuresc X X X X
Blood pressure & cardiovascular biomarkersd X X X X
Health behaviors & lifestyle measurementse X X X X
  1. a Stoop test (Victoria version) & Color Trails test b 3 MS, Digit Symbol Modalities test, COWAT, and Hopkins Verbal hearing test c Includes first language, level of education, height, weight, abdominal circumference, family history & co-morbidity; d Includes total cholesterol, LDL-Cholesterol, HDL-Cholesterol, triglycerides, C-Reactive Protein, Hemoglobin, fasting glucose & creatinine;e Includes physical activity, smoking history & alcohol use, SF-36 & IADL